The current status of oncolytic viral therapy for head and neck cancer.

about

Oncolytic Adenoviruses in Gastrointestinal Cancers.Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer.

P2860

Q52726850-D11D0E7E-2053-4D0B-BC61-6EF72A700474 Q55004955-3007D2FB-229F-45A6-BD7A-6A763889A2C6

P2860

The current status of oncolytic viral therapy for head and neck cancer.

Item

http://www.wikidata.org/entity/Q52859083

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The current status of oncolytic viral therapy for head and neck cancer.

@en

The current status of oncolytic viral therapy for head and neck cancer.

@nl

type

Item

label

The current status of oncolytic viral therapy for head and neck cancer.

@en

The current status of oncolytic viral therapy for head and neck cancer.

@nl

prefLabel

The current status of oncolytic viral therapy for head and neck cancer.

@en

The current status of oncolytic viral therapy for head and neck cancer.

@nl

P1476

The current status of oncolytic viral therapy for head and neck cancer.

@en

P2093

Balveen Kaur

http://www.w3.org/2001/XMLSchema#string

Chadwick L Wright

http://www.w3.org/2001/XMLSchema#string

Matthew O Old

http://www.w3.org/2001/XMLSchema#string

Theodoros Teknos

http://www.w3.org/2001/XMLSchema#string

Trisha Wise-Draper

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT

Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

History of oncolytic viruses: genesis to genetic engineering.

Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma.

Genetically targeted cancer therapy: tumor destruction by PKR activation.

Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

P304

84-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.WJORL.2016.05.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204552

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5698520

http://www.w3.org/2001/XMLSchema#string

The current status of oncolytic viral therapy for head and neck cancer.

about

P2860

P2860

The current status of oncolytic viral therapy for head and neck cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932